Description

This curriculum spans the technical and operational breadth of a multi-phase genetic discovery program, comparable to the integrated analytics, governance, and translational workflows seen in large biobank studies or cross-institutional genomics consortia.

Module 1: Foundations of Quantitative Genetic Analysis in Genomic Data

Select appropriate study designs (e.g., case-control, cohort, family-based) based on trait heritability and population structure constraints.
Implement quality control pipelines for high-throughput genotype data, including missingness thresholds, Hardy-Weinberg equilibrium filtering, and sex chromosome consistency checks.
Choose between additive, dominant, and recessive genetic models based on biological plausibility and statistical fit in preliminary analyses.
Correct for batch effects in genotyping arrays by integrating principal components or using ComBat-like methods while preserving biological signal.
Estimate sample size requirements for detecting QTLs given minor allele frequency, effect size, and desired power using simulation frameworks.
Integrate imputation reference panels (e.g., 1000 Genomes, Haplotype Reference Consortium) based on ancestral match and imputation accuracy metrics (INFO scores).
Validate genotype-phenotype associations using orthogonal assays such as TaqMan or sequencing for top hits in discovery datasets.
Document data provenance and versioning for raw genotypes, imputed dosages, and phenotype files to ensure reproducibility across analysis stages.

Module 2: Population Structure and Confounding in Genetic Association Studies

Calculate genomic inflation factors (λ) and adjust test statistics using genomic control or linear mixed models to mitigate stratification bias.
Generate and interpret principal component analysis (PCA) plots from genome-wide SNPs to identify and adjust for ancestry outliers.
Decide between including top principal components as covariates versus using linear mixed models (LMMs) based on relatedness structure in the cohort.
Apply multidimensional scaling (MDS) to compare study samples against reference populations (e.g., HapMap, gnomAD) for ancestry assignment.
Exclude or stratify samples with ambiguous or admixed ancestry when meta-analyzing across diverse populations.
Assess the impact of cryptic relatedness using identity-by-descent (IBD) estimation and determine thresholds for sample exclusion or kinship matrix inclusion.
Use ancestry-informative markers (AIMs) to refine population labels when self-reported data are inconsistent or missing.
Adjust analysis pipelines for population-specific linkage disequilibrium (LD) patterns that affect imputation and association test performance.

Module 3: Genome-Wide Association Study (GWAS) Implementation and Optimization

Configure PLINK or REGENIE workflows for efficient GWAS execution on large biobank-scale datasets using parallel computing and chunked analysis.
Define significance thresholds using Bonferroni correction or permutation testing based on effective number of independent tests.
Implement quantile normalization for non-normally distributed quantitative traits prior to linear regression modeling.
Compare logistic versus linear regression models for binary traits based on case-control balance and population prevalence.
Integrate covariate selection algorithms (e.g., stepwise, LASSO) to balance confounder adjustment with model overfitting risks.
Monitor and log per-SNP call rates, minor allele frequencies, and effect direction consistency across batches.
Use efficient mixed-model association expedited (EMMAX) or BOLT-LMM to scale GWAS in structured populations without excessive computational cost.
Validate association results in independent cohorts or use cross-validation within large datasets to assess replicability.

Module 4: Heritability Estimation and Polygenic Architecture Modeling

Estimate SNP-based heritability using GCTA-GREML with appropriate kinship matrix construction and convergence diagnostics.
Interpret differences between narrow-sense heritability estimates from family studies versus SNP-based methods.
Apply LD Score Regression to distinguish polygenic signal from inflation due to cryptic relatedness or population structure.
Partition heritability by functional annotation (e.g., coding, regulatory regions) using stratified LD score regression.
Fit mixture models (e.g., Gaussian mixture models) to effect size distributions to infer genetic architecture (infinitesimal vs. sparse).
Compare heritability estimates across ancestries and assess portability of polygenic scores in diverse populations.
Use Haseman-Elston regression as an alternative for heritability estimation in family-based designs with limited sample sizes.
Adjust for ascertainment bias in heritability estimates from case-control studies using liability threshold models.

Module 5: Polygenic Risk Score (PRS) Development and Calibration

Select clumping and thresholding (C+T), LDpred, or PRS-CS methods based on training sample size, LD structure, and trait architecture.
Optimize p-value thresholds in C+T using validation set performance rather than discovery set significance.
Adjust PRS for ancestry by applying principal components as covariates or using ancestry-specific weights when available.
Calibrate PRS effect sizes using logistic regression in validation cohorts to ensure proper risk scaling.
Assess overfitting by comparing PRS performance in training versus hold-out samples using cross-validation.
Integrate functional priors (e.g., epigenomic annotations) in Bayesian PRS methods to improve prediction accuracy.
Quantify the proportion of phenotypic variance explained by PRS using Nagelkerke’s R² or liability-scale transformations.
Document PRS model version, SNP weights, reference panel, and software parameters for audit and deployment.

Module 6: Functional Annotation and Post-GWAS Analysis

Map GWAS hits to genes using positional, eQTL, or chromatin interaction-based criteria (e.g., promoter capture Hi-C).
Perform gene-set enrichment analysis using MAGMA or FUMA with appropriate multiple testing corrections.
Integrate single-cell eQTL datasets to prioritize causal cell types and tissues for trait-associated loci.
Apply fine-mapping methods (e.g., FINEMAP, SuSiE) to compute posterior probabilities of causality for SNPs in LD blocks.
Use chromatin state annotations (e.g., ChromHMM, Segway) to prioritize non-coding variants in regulatory elements.
Validate predicted regulatory effects using reporter assays or CRISPR-based perturbation in relevant cell models.
Link GWAS loci to drug targets using databases like Open Targets, considering directionality of effect and tissue specificity.
Generate locus zoom plots and regional association visualizations for publication and stakeholder review.

Module 7: Cross-Ancestry and Translational Considerations in Genetic Discovery

Evaluate portability of GWAS results and PRS across populations by comparing effect size correlations and prediction R².
Identify and exclude variants with large allele frequency differences or flipped LD patterns in target populations.
Use multi-ancestry meta-analysis frameworks (e.g., MANTRA, MR-MEGA) to improve power and fine-mapping resolution.
Address health disparity risks by auditing PRS performance across demographic subgroups during development.
Engage with biobanks of underrepresented ancestries to co-develop analysis plans and data-sharing agreements.
Adjust for environmental heterogeneity when interpreting genetic effects across populations with differing lifestyles or exposures.
Apply trans-ethnic fine-mapping to narrow causal intervals by leveraging differences in LD structure across groups.
Document limitations of generalizability in study reports and avoid overinterpretation of results in non-represented groups.

Module 8: Data Integration and Systems-Level Interpretation

Construct gene regulatory networks using eQTL and chromatin interaction data to contextualize GWAS findings.
Integrate proteomic and metabolomic QTLs (pQTLs, mQTLs) to trace genetic effects through molecular layers to phenotypes.
Apply Mendelian Randomization to infer causal relationships between molecular traits and complex diseases using GWAS summary statistics.
Select instrumental variables based on strength (F-statistic > 10), specificity, and absence of pleiotropy.
Use colocalization analysis (e.g., COLOC, eCAVIAR) to assess shared causal variants between QTLs and GWAS signals.
Model epistatic interactions using regression frameworks with interaction terms, adjusting for multiple testing burden.
Validate network predictions using independent perturbation datasets (e.g., CRISPR screens, knockout models).
Generate interactive dashboards for exploring multi-omics associations using tools like Shiny or LocusExplorer.

Module 9: Ethical, Legal, and Operational Governance in Genetic Data Use

Implement data access controls based on IRB-approved protocols and data use limitations (DUOs) for controlled-access repositories.
Conduct data protection impact assessments (DPIAs) for genomic datasets containing identifiable or sensitive information.
Apply de-identification techniques such as k-anonymity or synthetic data generation for sharing summary statistics.
Establish audit trails for data access, analysis workflows, and model deployment in compliance with GDPR or HIPAA.
Design consent processes that address future use, data sharing, and return of results for biobank participants.
Monitor for incidental findings using ACMG guidelines and define protocols for clinical referral pathways.
Coordinate with institutional review boards to update protocols when new analytical methods (e.g., PRS) introduce novel risks.
Develop breach response plans specific to genomic data, including re-identification risk assessment and stakeholder notification.